For these reasons, we co-cultured MSCs from ITP patients with healthy PHA activated T-cells and analyzed lymphocytes viability and tumor necrosis factor-alpha (TNF-α) release after treatments. This evidence concerns the gene TNF and autoimmune thrombocytopenic purpura.